St. Marianna University School of Medicine;KYOWA HAKKO KIRIN CO., LTD
发明人:
Yoshihisa Yamano
申请号：
US13936290
公开号：
US09642910B2
申请日:
2013.07.08
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The object of the present invention is to provide a new therapeutic method and a new therapeutic agent that are different from known therapeutic medicines for human T cell leukemia virus type-1 (also known as human T lymphotropic virus type-1) associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers. The present invention relates to a therapeutic method and a therapeutic agent for human T cell leukemia virus type-1 (HTLV-1) associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers (ACs), which is characterized by reducing HTLV-1 virus-infected cells using an anti-human CC-chemokine receptor 4 (CCR4) antibody.
